发明名称 INDOLE DERIVATIVE AND PHARMACOLOGICALLY ACCEPTABLE SALT OF SAME
摘要 The present invention provides a compound represented by general formula (I) (in the formula: A is a benzene ring, pyridine ring, or the like; Y1 is an alkylene group having 1-6 carbon atoms, or the like; Y2 is a single bond or the like; Z is -C(=O)-NHSO2R6, an acidic 5-membered heterocycle group, or the like; R1 is a hydrogen atom or the like; R2 is a phenyl group, a 5-membered aromatic heterocycle group, or the like; R3 is a halogen atom, an alkoxy group having 1-6 carbon atoms, or the like; R4 is a hydrogen atom, a halogen atom, or the like; R5 is a hydrogen atom or the like; and R6 represents an alkyl group having 1-6 carbon atoms, or the like) having EP1 receptor antagonism, and a pharmacologically acceptable salt of same. Furthermore, the compound (I) can be used as a therapeutic drug or a preventative drug for various symptoms of LUTS, particularly OABs.
申请公布号 WO2012102255(A1) 申请公布日期 2012.08.02
申请号 WO2012JP51402 申请日期 2012.01.24
申请人 KISSEI PHARMACEUTICAL CO., LTD.;KYORIN PHARMACEUTICAL CO., LTD.;TATANI, KAZUYA;KONDO, ATSUSHI;KONDO, TATSUHIRO;KAWAMURA, NAOHIRO 发明人 TATANI, KAZUYA;KONDO, ATSUSHI;KONDO, TATSUHIRO;KAWAMURA, NAOHIRO
分类号 C07D209/18;A61K31/404;A61K31/41;A61K31/427;A61K31/4439;A61K31/444;A61K31/506;A61K45/00;A61P13/02;A61P13/10;A61P43/00;C07D401/06;C07D401/14;C07D403/10;C07D405/06;C07D405/14;C07D409/14;C07D413/14;C07D417/06;C07D419/14 主分类号 C07D209/18
代理机构 代理人
主权项
地址